RE:RE:5 major failures that could have been transformative Ciao wrote: Correction on the functional drink target:
Functional drink: A functional drink with oat-BG impregnated with CoQ10 was highlighted in the Nov. 2018 corporate presentation with “Next Steps: Partnering and sales!” It was kept as a corporate milestone up to 2020 then taken out in 2021 without explanation.
It turned out oat beta glucan was viewed as too costly to process. Few people get it perfect on the first attempt. That's why speeches are re-written. That's why professional sports players practice so much. Heck, you couldn't even get your Stockhouse post right the first time and had to correct it.
Informed by the discussions with industry CZO has developed second generation carriers that answer the questions the prototype couldn't. Yeast beta glucan is easier to process. It is believed cheaper to process. The bioavailability results of PGX-CoQ10 also blew away PGX-oat beta glucan. CZO also appears to have developed a Trojan Horse that can hijack macrophages. Dr. Kolb believes PGX-YBG could profoundly change the landscape for fibrosis treatment if preclinical results are replicated in humans. PGX-YBG is also has 5X more binding efficiency to immume stimulating receptors making it a potential gold standard yeast beta glucan immune booster. Gilles should have been given a $10 millin bonus for turning PGX-oat beta glucan into PGX-YBG.